WO2006024284A3 - Atrium patch - Google Patents

Atrium patch Download PDF

Info

Publication number
WO2006024284A3
WO2006024284A3 PCT/DE2005/001528 DE2005001528W WO2006024284A3 WO 2006024284 A3 WO2006024284 A3 WO 2006024284A3 DE 2005001528 W DE2005001528 W DE 2005001528W WO 2006024284 A3 WO2006024284 A3 WO 2006024284A3
Authority
WO
WIPO (PCT)
Prior art keywords
atrium
patch
genitalia
lips
active agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE2005/001528
Other languages
English (en)
French (fr)
Other versions
WO2006024284A2 (de
Inventor
Ulrike Vollmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ND ENTWICKLUNG MBH LABTEC GESELLSCHAFT fur TECHNOLOGISCHE FORSCHUNG U
ND ENTWICKLUNG MBH LABTEC GES
Original Assignee
ND ENTWICKLUNG MBH LABTEC GESELLSCHAFT fur TECHNOLOGISCHE FORSCHUNG U
ND ENTWICKLUNG MBH LABTEC GES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ND ENTWICKLUNG MBH LABTEC GESELLSCHAFT fur TECHNOLOGISCHE FORSCHUNG U, ND ENTWICKLUNG MBH LABTEC GES filed Critical ND ENTWICKLUNG MBH LABTEC GESELLSCHAFT fur TECHNOLOGISCHE FORSCHUNG U
Priority to EP05782111A priority Critical patent/EP1784170B1/de
Priority to DE502005002524T priority patent/DE502005002524D1/de
Priority to US11/661,712 priority patent/US9320721B2/en
Publication of WO2006024284A2 publication Critical patent/WO2006024284A2/de
Publication of WO2006024284A3 publication Critical patent/WO2006024284A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Pflasterzubereitung für die Administration von Wirk­stoffen in und an Körperöffnungen wie z.B. die Mundhöh­le, die Lippen, die Genitalien etc.
PCT/DE2005/001528 2004-09-01 2005-09-01 Atrium patch Ceased WO2006024284A2 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP05782111A EP1784170B1 (de) 2004-09-01 2005-09-01 Atrium patch
DE502005002524T DE502005002524D1 (en) 2004-09-01 2005-09-01 Atrium patch
US11/661,712 US9320721B2 (en) 2004-09-01 2005-09-01 Mucoadhesive patch with opposite ratios of nonionic and anionic hydrocolloids in adhesive and backing layer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004042616 2004-09-01
DE102004042616.3 2004-09-01

Publications (2)

Publication Number Publication Date
WO2006024284A2 WO2006024284A2 (de) 2006-03-09
WO2006024284A3 true WO2006024284A3 (de) 2006-08-31

Family

ID=35705271

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2005/001528 Ceased WO2006024284A2 (de) 2004-09-01 2005-09-01 Atrium patch

Country Status (6)

Country Link
US (1) US9320721B2 (de)
EP (1) EP1784170B1 (de)
AT (1) ATE383150T1 (de)
DE (1) DE502005002524D1 (de)
ES (1) ES2299082T3 (de)
WO (1) WO2006024284A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9320721B2 (en) 2004-09-01 2016-04-26 Tesa Labtec Gmbh Mucoadhesive patch with opposite ratios of nonionic and anionic hydrocolloids in adhesive and backing layer
DE102005050654A1 (de) * 2005-10-20 2007-04-26 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Lippenpflaster
US8932560B2 (en) * 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
RU2497679C2 (ru) 2008-10-02 2013-11-10 Милан Инк. Способ получения многослойного клеящегося ламинированного материала
EP2196197A1 (de) 2008-12-15 2010-06-16 Bouty S.P.A. Antiviral wirkendes Pflaster
AU2013233943B2 (en) * 2012-03-14 2017-10-19 Izun Pharmaceuticals Corp Novel methods and compositions for treatment of disease
EP3027235A1 (de) 2013-07-30 2016-06-08 Musculoskeletal Transplant Foundation Aus einem azellulären weichgewebe gewonnene matrizen und verfahren zur herstellung davon
US9925127B2 (en) 2014-10-10 2018-03-27 Funky Junk, Inc. Flavored genital hygiene towelette, assembly and method of use
US11793980B2 (en) 2019-08-31 2023-10-24 Celero Systems, Inc. Intestinal attachment device

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3699963A (en) * 1969-10-31 1972-10-24 Alza Corp Therapeutic adhesive patch
DE19856101A1 (de) * 1998-12-04 2000-06-08 Labtec Gmbh Mundhöhlen-Matrixpflaster
EP1034780A2 (de) * 1999-03-05 2000-09-13 Altergon S.A. Mit Betamethasone und Hyaluronsaüre behandeltes dünnes adhäsives Pflaster für die Behandlung von Psoriasis, Dermatitis, und Dermatosis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0645536B2 (ja) * 1989-01-31 1994-06-15 日東電工株式会社 口腔粘膜貼付剤および口腔粘膜貼付製剤
DE69908472T2 (de) * 1998-03-31 2004-05-06 Oji Paper Co., Ltd. Aufzeichnungsmaterial für das Tintenstrahldruckverfahren
DE19832519A1 (de) 1998-07-20 2000-01-27 Hartmut Oswald Arzneimittelzubereitungen zur topischen Behandlung mukokutaner Herpesinfektionen sowie der Keratitis herpetica des Auges
AU3853800A (en) 1999-01-11 2000-08-01 Ahmet Degirmenci Pharmaceutical forms and methods for penetration continuity
US6210699B1 (en) 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
DE19932603A1 (de) * 1999-07-13 2001-01-25 Gruenenthal Gmbh Wirkstoffhaltiger Mehrschichtfilm aus in situ vernetzten hydrophilen Polymeren
US6264981B1 (en) 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
DE10252726B4 (de) * 2002-11-13 2008-05-08 Lts Lohmann Therapie-Systeme Ag Mehrschichtiges transmucosales therapeutisches System
IL153124A (en) * 2002-11-27 2010-06-30 Herbal Synthesis Corp Solid composition that can be glued to the lining
US9320721B2 (en) 2004-09-01 2016-04-26 Tesa Labtec Gmbh Mucoadhesive patch with opposite ratios of nonionic and anionic hydrocolloids in adhesive and backing layer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3699963A (en) * 1969-10-31 1972-10-24 Alza Corp Therapeutic adhesive patch
DE19856101A1 (de) * 1998-12-04 2000-06-08 Labtec Gmbh Mundhöhlen-Matrixpflaster
EP1034780A2 (de) * 1999-03-05 2000-09-13 Altergon S.A. Mit Betamethasone und Hyaluronsaüre behandeltes dünnes adhäsives Pflaster für die Behandlung von Psoriasis, Dermatitis, und Dermatosis

Also Published As

Publication number Publication date
WO2006024284A2 (de) 2006-03-09
ES2299082T3 (es) 2008-05-16
DE502005002524D1 (en) 2008-02-21
EP1784170B1 (de) 2008-01-09
US9320721B2 (en) 2016-04-26
US20080274164A1 (en) 2008-11-06
EP1784170A2 (de) 2007-05-16
ATE383150T1 (de) 2008-01-15

Similar Documents

Publication Publication Date Title
WO2005016286A8 (en) Pyrazine modulators of cannabinoid receptors
EP1765081B8 (de) Hautdesinfektionsmittel auf wasserstoffperoxid-basis
WO2007064885A3 (en) Oral care compositions, methods, devices and systems
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
WO2005037199A3 (en) Pyrazole derivatives as cannabinoid receptor modulators
WO2008048589A3 (en) Compounds and methods for treatment of hcv
WO2006133271A3 (en) Compositions and methods relating to target-specific photodynamic therapy
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
WO2008098168A3 (en) High-dose, long-acting ectoparasiticide for extended control
WO2005091853A3 (en) Methods and compositions for treating il-13 related pathologies
PT1638582E (pt) Uso de ácido hialurónico para a preparação de composições para o tratamento de aftas recorrentes da cavidade bucal
EP1745004B8 (de) Arylketonverbindungen und zusammensetzungen zur wirkstofffreisetzung
WO2006056696A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
WO2006121522A3 (en) Implantable sensors and pumps, anti-scarring agents, and therapeutic compositions
WO2006088903A3 (en) Pyrazole compounds
WO2006054182A3 (en) Phosphoindoles as hiv inhibitors
WO2007003264A3 (de) Polyasparaginsäurederivate in polysiloxan-haltigen beschichtungsmitteln
EP1786433A4 (de) Betulinol-derivate als anti-hiv-mittel
WO2007025994A3 (fr) Utilisation d'au moins un 2-alkyle furane, a titre de principe actif depigmentant ou eclaircissant
WO2008024846A3 (en) Brimonidine and timolol compositions
WO2006101909A3 (en) Combination therapy for treating or preventing diseases
TWI349545B (en) Pharmaceutical composition
WO2004105780A3 (en) Compositions comprising gastrin compounds and their use in diabetes
WO2009085198A3 (en) Combination of metformin r-(+)-lipoate and antiobesity agents for the treatment of diabetic hyperglycemia and diabetic complications
WO2005105062A3 (de) Kombinationspräparate enthaltend 2-methylthiazolidin-2,4-dicarbonsäure

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005782111

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2005782111

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 11661712

Country of ref document: US

WWG Wipo information: grant in national office

Ref document number: 2005782111

Country of ref document: EP